HandyLab sells the Jaguar molecular diagnostics system, which incorporates clinical sample preparation, nucleic acid extraction, microfluidic real-time PCR amplification and detection. The Ann Arbor, Mich.-based firm launched the system in November 2008.
BD said that it plans to place its BD GeneOhm assays for methicillin-resistant
The acquisition follows an alliance between the firms begun earlier this year aimed at placing the GeneOhm tests on the Jaguar system.
"We believe this new platform enables both our healthcare-associated infections offering and future expansion into other molecular opportunities," BD President Vincent Forlenza said in a statement.
BD said that it will provide more information on the acquisition during its fiscal fourth-quarter conference call on Nov. 4.
XTractor Premium - A Platform for discovery, knowledge sharing, analysis and modelling of published biomedical facts.
- The only Knowledgebase which provides "manually" annotated facts from PubMed on a weekly basis
- Innovative Features like Semantic Search, Concept Linking, Bibliographic search, Save, Export and Visualize
- Only Knowledgebase with daily updations from PubMed
- XTractor Premium now at an Special Introductory Offer. Subscribe now and save!
- Request for a Trial